Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities

2023; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês

10.1002/mdc3.13903

2330-1619

Ai Huey Tan, Mario Cornejo‐Olivas, Njideka Okubadejo, Pramod Kumar Pal, Gerard Saranza, Paula Saffie Awad, Azlina Ahmad‐Annuar, Artur Francisco Schumacher Schuh, Kigocha Okeng’o, Ignácio F. Mata, Emilia Gatto, Shen‐Yang Lim,

Parkinson's Disease Mechanisms and Treatments

Movement Disorders Clinical PracticeVolume 11, Issue 1 p. 14-20 VIEWPOINT Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities Ai Huey Tan MD, PhD, FRCP, Corresponding Author Ai Huey Tan MD, PhD, FRCP [email protected] orcid.org/0000-0002-2979-3839 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Correspondence to: Dr. Ai Huey Tan, Neurology Laboratory, 6th Floor, South Tower, University of Malaya Medical Centre, 50603 Kuala Lumpur, Malaysia; E-mail: [email protected].Search for more papers by this authorMario Cornejo-Olivas MD, Mario Cornejo-Olivas MD orcid.org/0000-0001-6313-5680 Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, PeruSearch for more papers by this authorNjideka Okubadejo MBChB, FMCP, FAAN, Njideka Okubadejo MBChB, FMCP, FAAN orcid.org/0000-0003-2975-8803 Department of Medicine, College of Medicine, University of Lagos, Lagos, NigeriaSearch for more papers by this authorPramod Kumar Pal MD, DM, FRCP, Pramod Kumar Pal MD, DM, FRCP orcid.org/0000-0002-4085-2377 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, IndiaSearch for more papers by this authorGerard Saranza MD, Gerard Saranza MD orcid.org/0000-0001-8322-4226 Movement Disorders Service, Section of Neurology, Department of Internal Medicine, Chong Hua Hospital and Vicente Sotto Memorial Medical Center, Cebu, PhilippinesSearch for more papers by this authorPaula Saffie-Awad MD, PhD, Paula Saffie-Awad MD, PhD orcid.org/0000-0002-8056-365X CETRAM-Centro de Estudios de Transtornos del Movimiento, Clínica Santa María, Santiago, ChileSearch for more papers by this authorAzlina Ahmad-Annuar PhD, Azlina Ahmad-Annuar PhD orcid.org/0000-0001-6329-4366 Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaSearch for more papers by this authorArtur F. Schumacher-Schuh MD, PhD, Artur F. Schumacher-Schuh MD, PhD orcid.org/0000-0002-8722-0908 Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, BrazilSearch for more papers by this authorKigocha Okeng'o MD, MMed, MSc, Kigocha Okeng'o MD, MMed, MSc orcid.org/0000-0003-2615-9274 T.M.J. Super Specialized Polyclinic, Dar es Salaam, TanzaniaSearch for more papers by this authorIgnacio F. Mata PhD, Ignacio F. Mata PhD orcid.org/0000-0003-1198-0633 Genomic Medicine Institute, Lerner Research Institute, Genomic Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USASearch for more papers by this authorEmilia M. Gatto MD, FAAN, Emilia M. Gatto MD, FAAN orcid.org/0000-0002-1346-5443 Department of Neurology, Hospital Sanatorio de la Trinidad Mitre, Instituto de Neurociencias Buenos Aires, School of Medicine, Buenos Aires University, Buenos Aires, ArgentinaSearch for more papers by this authorShen-Yang Lim MD, FRACP, Shen-Yang Lim MD, FRACP orcid.org/0000-0002-6942-2522 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaSearch for more papers by this author Ai Huey Tan MD, PhD, FRCP, Corresponding Author Ai Huey Tan MD, PhD, FRCP [email protected] orcid.org/0000-0002-2979-3839 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Correspondence to: Dr. Ai Huey Tan, Neurology Laboratory, 6th Floor, South Tower, University of Malaya Medical Centre, 50603 Kuala Lumpur, Malaysia; E-mail: [email protected].Search for more papers by this authorMario Cornejo-Olivas MD, Mario Cornejo-Olivas MD orcid.org/0000-0001-6313-5680 Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, PeruSearch for more papers by this authorNjideka Okubadejo MBChB, FMCP, FAAN, Njideka Okubadejo MBChB, FMCP, FAAN orcid.org/0000-0003-2975-8803 Department of Medicine, College of Medicine, University of Lagos, Lagos, NigeriaSearch for more papers by this authorPramod Kumar Pal MD, DM, FRCP, Pramod Kumar Pal MD, DM, FRCP orcid.org/0000-0002-4085-2377 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, IndiaSearch for more papers by this authorGerard Saranza MD, Gerard Saranza MD orcid.org/0000-0001-8322-4226 Movement Disorders Service, Section of Neurology, Department of Internal Medicine, Chong Hua Hospital and Vicente Sotto Memorial Medical Center, Cebu, PhilippinesSearch for more papers by this authorPaula Saffie-Awad MD, PhD, Paula Saffie-Awad MD, PhD orcid.org/0000-0002-8056-365X CETRAM-Centro de Estudios de Transtornos del Movimiento, Clínica Santa María, Santiago, ChileSearch for more papers by this authorAzlina Ahmad-Annuar PhD, Azlina Ahmad-Annuar PhD orcid.org/0000-0001-6329-4366 Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaSearch for more papers by this authorArtur F. Schumacher-Schuh MD, PhD, Artur F. Schumacher-Schuh MD, PhD orcid.org/0000-0002-8722-0908 Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, BrazilSearch for more papers by this authorKigocha Okeng'o MD, MMed, MSc, Kigocha Okeng'o MD, MMed, MSc orcid.org/0000-0003-2615-9274 T.M.J. Super Specialized Polyclinic, Dar es Salaam, TanzaniaSearch for more papers by this authorIgnacio F. Mata PhD, Ignacio F. Mata PhD orcid.org/0000-0003-1198-0633 Genomic Medicine Institute, Lerner Research Institute, Genomic Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USASearch for more papers by this authorEmilia M. Gatto MD, FAAN, Emilia M. Gatto MD, FAAN orcid.org/0000-0002-1346-5443 Department of Neurology, Hospital Sanatorio de la Trinidad Mitre, Instituto de Neurociencias Buenos Aires, School of Medicine, Buenos Aires University, Buenos Aires, ArgentinaSearch for more papers by this authorShen-Yang Lim MD, FRACP, Shen-Yang Lim MD, FRACP orcid.org/0000-0002-6942-2522 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaSearch for more papers by this author First published: 21 October 2023 https://doi.org/10.1002/mdc3.13903 Relevant disclosures and conflict of interest are listed at the end of this article. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 World-Bank. Low and Middle Income: World Bank Data. Washington, DC: World Bank Group; 2023. Available from: https://data.worldbank.org/country/XO accessed 22 April 2023. Google Scholar 2 Global Burden of Disease Health Financing Collaborator. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050. Lancet 2019; 393(10187): 2233–2260. https://doi.org/10.1016/S0140-6736(19)30841-4. 10.1016/S0140-6736(19)30841-4 PubMedWeb of Science®Google Scholar 3Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell 2019; 177(1): 26–31. https://doi.org/10.1016/j.cell.2019.02.048. 10.1016/j.cell.2019.02.048 CASPubMedWeb of Science®Google Scholar 4Elsayed I, Martinez-Carrasco A, Cornejo-Olivas M, Bandres-Ciga S. Mapping the diverse and inclusive future of Parkinson's disease genetics and its widespread impact. Genes (Basel) 2021; 12(11):1681. https://doi.org/10.3390/genes12111681. 10.3390/genes12111681 Web of Science®Google Scholar 5 UN Committee on Economic SaCRC. General Comment No. 14: The Right to the Highest Attainable Standard of Health (Art. 12 of the Covenant) 2000 Available from: https://www.refworld.org/docid/4538838d0.html accessed 8 April 2023. Google Scholar 6Gatto EM, Walker RH, Gonzalez C, et al. Worldwide barriers to genetic testing for movement disorders. Eur J Neurol 2021; 28(6): 1901–1909. https://doi.org/10.1111/ene.14826. 10.1111/ene.14826 PubMedWeb of Science®Google Scholar 7Wetterstrand KA. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program (GSP). Bethesda, MD: National Human Genome Research Institute; 2023. https://www.genome.gov/sequencingcostsdata [accessed 8 April 2023]. Google Scholar 8Schiess N, Cataldi R, Okun MS, et al. Six action steps to address global disparities in Parkinson disease: a World Health Organization priority. JAMA Neurol 2022; 79: 929–936. https://doi.org/10.1001/jamaneurol.2022.1783. 10.1001/jamaneurol.2022.1783 PubMedWeb of Science®Google Scholar 9Hamid E, Ayele BA, Massi DG, et al. Availability of therapies and Services for Parkinson's disease in Africa: a continent-wide survey. Mov Disord 2021; 36(10): 2393–2407. https://doi.org/10.1002/mds.28669. 10.1002/mds.28669 CASPubMedWeb of Science®Google Scholar 10Lim S-Y, Tan AH, Ahmad-Annuar A, et al. Parkinson's disease in the Western Pacific region. Lancet Neurol 2019; 18(9): 865–879. https://doi.org/10.1016/s1474-4422(19)30195-4. 10.1016/S1474-4422(19)30195-4 PubMedWeb of Science®Google Scholar 11Guio H, Poterico JA, Levano KS, et al. Genetics and genomics in Peru: clinical and research perspective. Mol Genet Genomic Med 2018; 6(6): 873–886. https://doi.org/10.1002/mgg3.533. 10.1002/mgg3.533 PubMedWeb of Science®Google Scholar 12Margarit SB, Alvarado M, Alvarez K, Lay-Son G. Medical genetics and genetic counseling in Chile. J Genet Couns 2013; 22(6): 869–874. https://doi.org/10.1007/s10897-013-9607-1. 10.1007/s10897-013-9607-1 PubMedWeb of Science®Google Scholar 13Prasad SP, Pramod K. Early Onset Parkinson's Disease in India: Challenges in Diagnosis and Management: World Neurology Foundation. Benson, VT: World Neurology Foundation; 2023. Available from: https://www.worldneurology.com/post/early-onset-parkinson-s-disease-in-india-challenges-in-diagnosis-and-management accessed 23 April 2023. Google Scholar 14Tan EK, Lee J, Hunter C, Shinawi L, Fook-Chong S, Jankovic J. Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population. J Neurol Sci 2007; 252(2): 113–120. https://doi.org/10.1016/j.jns.2006.10.016. 10.1016/j.jns.2006.10.016 PubMedWeb of Science®Google Scholar 15Meilleur KG, Coulibaly S, Traore M, et al. Genetic testing and counseling for hereditary neurological diseases in Mali. J Community Genet 2011; 2(1): 33–42. https://doi.org/10.1007/s12687-011-0038-0. 10.1007/s12687-011-0038-0 PubMedGoogle Scholar 16Anderson KE, Eberly S, Marder KS, et al. The choice not to undergo genetic testing for Huntington disease: results from the PHAROS study. Clin Genet 2019; 96(1): 28–34. https://doi.org/10.1111/cge.13529. 10.1111/cge.13529 CASPubMedWeb of Science®Google Scholar 17Appelbaum PS, Burke W, Parens E, et al. Is there a way to reduce the inequity in variant interpretation on the basis of ancestry? Am J Hum Genet 2022; 109(6): 981–988. https://doi.org/10.1016/j.ajhg.2022.04.012. 10.1016/j.ajhg.2022.04.012 CASPubMedWeb of Science®Google Scholar 18Chancel L, Piketty T, Saez E, Zucman G, et al. World Inequality Report; 2022. Google Scholar 19Zhong A, Darren B, Loiseau B, He LQB, Chang T, Hill J, Dimaras H. Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: a systematic review. Genet Med 2021; 23(12): 2270–2280. https://doi.org/10.1038/s41436-018-0090-9. 10.1038/s41436-018-0090-9 PubMedWeb of Science®Google Scholar 20Choo XY, Lim SY, Chinna K, et al. Understanding patients' and caregivers' perspectives and educational needs in Parkinson's disease: a multi-ethnic Asian study. Neurol Sci 2020; 41(10): 2831–2842. https://doi.org/10.1007/s10072-020-04396-4. 10.1007/s10072-020-04396-4 PubMedWeb of Science®Google Scholar 21Mokaya J, Gray WK, Carr J. Beliefs, knowledge and attitudes towards Parkinson's disease among a Xhosa speaking black population in South Africa: a cross-sectional study. Parkinsonism Relat Disord 2017; 41: 51–57. https://doi.org/10.1016/j.parkreldis.2017.05.009. 10.1016/j.parkreldis.2017.05.009 PubMedWeb of Science®Google Scholar 22Fothergill-Misbah N. The lived experience of stigma and parkinson's disease in Kenya: a public health challenge. BMC Public Health 2023; 23(1): 364. https://doi.org/10.1186/s12889-023-15278-7. 10.1186/s12889-023-15278-7 PubMedWeb of Science®Google Scholar 23Mshana G, Dotchin CL, Walker RW. We call it the shaking illness': perceptions and experiences of Parkinson's disease in rural northern Tanzania. BMC Public Health 2011; 11:219. https://doi.org/10.1186/1471-2458-11-219. 10.1186/1471-2458-11-219 PubMedWeb of Science®Google Scholar 24Alcalay RN, Kehoe C, Shorr E, et al. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genet Med 2020; 22(3): 574–580. https://doi.org/10.1038/s41436-019-0684-x. 10.1038/s41436-019-0684-x PubMedWeb of Science®Google Scholar 25Saffie-Awad P, Mata I, Chana-Cuevas P. Genetic revolution: insights into new challenges and opportunities. Rev Med Chil 2023; 150(11): 1547–1548. Web of Science®Google Scholar 26Cook L, Schulze J, Verbrugge J, et al. The commercial genetic testing landscape for Parkinson's disease. Parkinsonism Relat Disord 2021; 92: 107–111. https://doi.org/10.1016/j.parkreldis.2021.10.001. 10.1016/j.parkreldis.2021.10.001 CASPubMedWeb of Science®Google Scholar 27Good JM, Atallah I, Castro Jimenez M, Benninger D, Kuntzer T, Superti-Furga A, Tran C. NGS-based diagnosis of treatable Neurogenetic disorders in adults: opportunities and challenges. Genes (Basel) 2021; 12(5):695. https://doi.org/10.3390/genes12050695. 10.3390/genes12050695 PubMedWeb of Science®Google Scholar 28Vollstedt EJ, Schaake S, Lohmann K, et al. Embracing monogenic Parkinson's disease: the MJFF global genetic PD cohort. Mov Disord 2023; 38(2): 286–303. https://doi.org/10.1002/mds.29288. 10.1002/mds.29288 CASPubMedWeb of Science®Google Scholar 29Lim JLLK, Tan AH, Tay YW, et al. Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson's disease: mutational spectrum and clinical features. J Neural Transm (Vienna) 2022; 129: 37–48. https://doi.org/10.1007/s00702-021-02421-0. 10.1007/s00702-021-02421-0 CASPubMedWeb of Science®Google Scholar 30Hamamy H. Consanguineous marriages: preconception consultation in primary health care settings. J Community Genet 2012; 3(3): 185–192. https://doi.org/10.1007/s12687-011-0072-y. 10.1007/s12687-011-0072-y PubMedGoogle Scholar 31Fernandez-Eulate G, Carreau C, Benoist JF, et al. Diagnostic approach in adult-onset neurometabolic diseases. J Neurol Neurosurg Psychiatry 2022; 93(4): 413–421. https://doi.org/10.1136/jnnp-2021-328045. 10.1136/jnnp-2021-328045 PubMedWeb of Science®Google Scholar 32Tan AH, Mah JSY, Thong MK, Lim SY. Methylmalonic aciduria: a treatable disorder of which adult neurologists need to Be aware. Mov Disord Clin Pract 2016; 3(1): 104–105. https://doi.org/10.1002/mdc3.12237. 10.1002/mdc3.12237 PubMedWeb of Science®Google Scholar 33Cook L, Schulze J, Kopil C, et al. Genetic testing for Parkinson disease: are we ready? Neurol Clin Pract 2021; 11(1): 69–77. https://doi.org/10.1212/CPJ.0000000000000831. 10.1212/CPJ.0000000000000831 PubMedWeb of Science®Google Scholar 34Thomsen M, Lange LM, Klein C, Lohmann K. MDSGene: extending the list of isolated dystonia genes by VPS16, EIF2AK2, and AOPEP. Mov Disord 2023; 38(3): 507–508. https://doi.org/10.1002/mds.29327. 10.1002/mds.29327 PubMedWeb of Science®Google Scholar 35Schmidlen T, Schwartz M, DiLoreto K, Kirchner HL, Sturm AC. Patient assessment of chatbots for the scalable delivery of genetic counseling. J Genet Couns 2019; 28(6): 1166–1177. https://doi.org/10.1002/jgc4.1169. 10.1002/jgc4.1169 PubMedWeb of Science®Google Scholar 36Vrecar I, Hristovski D, Peterlin B. Telegenetics: an update on availability and use of telemedicine in clinical genetics service. J Med Syst 2017; 41(2): 21. https://doi.org/10.1007/s10916-016-0666-3. 10.1007/s10916-016-0666-3 PubMedWeb of Science®Google Scholar 37Srinivasan R, Ben-Pazi H, Dekker M, et al. Telemedicine for hyperkinetic movement disorders. Tremor Other Hyperkinet Mov (N Y) 2020; 10. https://doi.org/10.7916/tohm.v0.698. 10.7916/tohm.v0.698 PubMedWeb of Science®Google Scholar 38Schumacher-Schuh AF, Bieger A, Okunoye O, et al. Underrepresented populations in Parkinson's genetics research: current landscape and future directions. Mov Disord 2022; 37: 1593–1604. https://doi.org/10.1002/mds.29126. 10.1002/mds.29126 PubMedWeb of Science®Google Scholar 39Akinyemi RO, Owolabi MO, Oyeniyi T, et al. Neurogenomics in Africa: perspectives, progress, possibilities and priorities. J Neurol Sci 2016; 366: 213–223. https://doi.org/10.1016/j.jns.2016.05.006. 10.1016/j.jns.2016.05.006 CASPubMedWeb of Science®Google Scholar 40Trinh J, Luth T, Schaake S, et al. Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset. Brain 2023; 146(3): 1075–1082. https://doi.org/10.1093/brain/awac160. 10.1093/brain/awac160 PubMedWeb of Science®Google Scholar 41Tan AH, Lohmann K, Tay YW, et al. PINK1 p.Leu347Pro mutations in Malays: prevalence and illustrative cases. Parkinsonism Relat Disord 2020; 79: 34–39. https://doi.org/10.1016/j.parkreldis.2020.08.015. 10.1016/j.parkreldis.2020.08.015 PubMedWeb of Science®Google Scholar 42Gama MTD, Braga-Neto P, Rangel DM, et al. Autosomal recessive cerebellar ataxias in South America: a multicenter study of 1338 patients. Mov Disord 2022; 37(8): 1773–1774. https://doi.org/10.1002/mds.29046. 10.1002/mds.29046 PubMedWeb of Science®Google Scholar 43Jagota P, Lim SY, Pal PK, et al. Genetic movement disorders commonly seen in Asians. Mov Disord Clin Pract 2023; 10(6): 878–895. https://doi.org/10.1002/mdc3.13737. 10.1002/mdc3.13737 PubMedWeb of Science®Google Scholar 44Cowan JS, Kagedan RL, Graha GE, Heim-Myers B. Health care implications of the genetic non discrimination act. Can Fam Physician 2022; 68(9): 643–646. 10.46747/cfp.6809643 PubMedWeb of Science®Google Scholar Volume11, Issue1January 2024Pages 14-20 This article also appears in:MDCP Conference on Disparities and Inequities in the Availability of Therapies and Diagnostic Procedures Across Regions of the World - Kolkata, 2023 ReferencesRelatedInformation